Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jemma C Hopewell

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Circulation|April 28, 2012
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection StudySarah Parish, Alison Offer, Robert Clarke, et al.
European Journal of Preventive Cardiology|December 5, 2021
Are polygenic risk scores for systolic blood pressure and LDL-cholesterol associated with treatment effectiveness, and clinical outcomes among those on treatment?Neo M Tapela, Jennifer Collister, Xiaonan Liu, et al.
Circulation. Cardiovascular Quality and Outcomes|July 14, 2016
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare CostsSeamus Kent, Richard Haynes, Jemma C Hopewell, et al.
Atherosclerosis|July 8, 2022
Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS studyRobert Clarke, Imen Hammami, Paul Sherliker, et al.
Circulation. Genomic and Precision Medicine|June 17, 2025
Mechanistic Pathways Underlying Genetic Predisposition to Atrial Fibrillation Are Associated With Different Cardiac Phenotypes and Cardioembolic Stroke RiskParag R Gajendragadkar, Adam Von Ende, Federico Murgia, et al.
Plos Medicine|May 13, 2021
Assessment of the causal relevance of ECG parameters for risk of atrial fibrillation: A mendelian randomisation studyParag Ravindra Gajendragadkar, Adam Von Ende, Maysson Ibrahim, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 6, 2025
Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK BiobankC Fielder Camm, Adam Von Ende, Parag R Gajendragadkar, et al.
The New England Journal of Medicine|July 12, 2014
Effects of extended-release niacin with laropiprant in high-risk patients, Martin J Landray, Richard Haynes, et al.
Circulation|July 24, 2019
Impact of <i>ADCY9</i> Genotype on Response to AnacetrapibJemma C Hopewell, Maysson Ibrahim, Michael Hill, et al.
Annals of Neurology|November 2, 2018
Genome-wide meta-analysis identifies 3 novel loci associated with strokeRainer Malik, Kristiina Rannikmäe, Matthew Traylor, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Circulation|April 28, 2012
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection StudySarah Parish, Alison Offer, Robert Clarke, et al.
European Journal of Preventive Cardiology|December 5, 2021
Are polygenic risk scores for systolic blood pressure and LDL-cholesterol associated with treatment effectiveness, and clinical outcomes among those on treatment?Neo M Tapela, Jennifer Collister, Xiaonan Liu, et al.
Circulation. Cardiovascular Quality and Outcomes|July 14, 2016
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare CostsSeamus Kent, Richard Haynes, Jemma C Hopewell, et al.
Atherosclerosis|July 8, 2022
Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS studyRobert Clarke, Imen Hammami, Paul Sherliker, et al.
Circulation. Genomic and Precision Medicine|June 17, 2025
Mechanistic Pathways Underlying Genetic Predisposition to Atrial Fibrillation Are Associated With Different Cardiac Phenotypes and Cardioembolic Stroke RiskParag R Gajendragadkar, Adam Von Ende, Federico Murgia, et al.
Plos Medicine|May 13, 2021
Assessment of the causal relevance of ECG parameters for risk of atrial fibrillation: A mendelian randomisation studyParag Ravindra Gajendragadkar, Adam Von Ende, Maysson Ibrahim, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 6, 2025
Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK BiobankC Fielder Camm, Adam Von Ende, Parag R Gajendragadkar, et al.
The New England Journal of Medicine|July 12, 2014
Effects of extended-release niacin with laropiprant in high-risk patients, Martin J Landray, Richard Haynes, et al.
Circulation|July 24, 2019
Impact of <i>ADCY9</i> Genotype on Response to AnacetrapibJemma C Hopewell, Maysson Ibrahim, Michael Hill, et al.
Annals of Neurology|November 2, 2018
Genome-wide meta-analysis identifies 3 novel loci associated with strokeRainer Malik, Kristiina Rannikmäe, Matthew Traylor, et al.
Pageof 9